Position in HIMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$235,131
+$14,920 QoQ
Shares Held
6,782
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#337
of 504 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $2,556,716 across 7 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,394 | $755,311 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,229 | $544,215 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,383 | $403,185 | |
| 4 | ALKS |
Alkermes plc.
|
4,793 | $251,153 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
2,186 | $242,514 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
6,782 | $235,131 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
25,397 | $125,207 |
All Filings in HIMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,131 | 6,782 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $220,211 | 6,782 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $392,502 | 6,920 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $338,082 | 6,782 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $204,988 | 6,937 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||